Spire Healthcare Group (SPI) – Analysts’ Weekly Ratings Updates

Several brokerages have updated their recommendations and price targets on shares of Spire Healthcare Group (LON: SPI) in the last few weeks:

  • 3/12/2018 – Spire Healthcare Group had its price target lowered by analysts at JPMorgan Chase & Co. from GBX 339 ($4.68) to GBX 293 ($4.05). They now have a “neutral” rating on the stock.
  • 3/5/2018 – Spire Healthcare Group had its “neutral” rating reaffirmed by analysts at JPMorgan Chase & Co.. They now have a GBX 339 ($4.68) price target on the stock.
  • 3/5/2018 – Spire Healthcare Group had its price target lowered by analysts at Barclays PLC from GBX 270 ($3.73) to GBX 255 ($3.52). They now have an “equal weight” rating on the stock.
  • 3/2/2018 – Spire Healthcare Group was upgraded by analysts at Numis Securities Ltd to a “buy” rating. They now have a GBX 296 ($4.09) price target on the stock.
  • 3/1/2018 – Spire Healthcare Group had its “hold” rating reaffirmed by analysts at Liberum Capital. They now have a GBX 275 ($3.80) price target on the stock.
  • 2/2/2018 – Spire Healthcare Group is now covered by analysts at Barclays PLC. They set an “equal weight” rating and a GBX 270 ($3.73) price target on the stock.
  • 1/26/2018 – Spire Healthcare Group had its price target raised by analysts at Liberum Capital from GBX 270 ($3.73) to GBX 275 ($3.80). They now have a “hold” rating on the stock.
  • 1/17/2018 – Spire Healthcare Group was upgraded by analysts at Jefferies Group LLC to a “buy” rating. They now have a GBX 290 ($4.01) price target on the stock, up previously from GBX 259 ($3.58).
  • 1/16/2018 – Spire Healthcare Group had its “hold” rating reaffirmed by analysts at Liberum Capital. They now have a GBX 270 ($3.73) price target on the stock.
  • 1/16/2018 – Spire Healthcare Group had its “add” rating reaffirmed by analysts at Numis Securities Ltd. They now have a GBX 296 ($4.09) price target on the stock.

Shares of Spire Healthcare Group PLC (LON SPI) opened at GBX 219 ($3.03) on Tuesday. Spire Healthcare Group PLC has a 12 month low of GBX 206.40 ($2.85) and a 12 month high of GBX 362.10 ($5.00). The firm has a market capitalization of $886.39 and a P/E ratio of 5,475.00.

How to Become a New Pot Stock Millionaire

Spire Healthcare Group (LON:SPI) last issued its quarterly earnings data on Friday, March 2nd. The company reported GBX 14.40 ($0.20) earnings per share for the quarter, missing analysts’ consensus estimates of GBX 14.60 ($0.20) by GBX (0.20) ($0.00). Spire Healthcare Group had a net margin of 1.85% and a return on equity of 1.71%. The business had revenue of £931.70 million for the quarter.

The firm also recently disclosed a dividend, which will be paid on Tuesday, June 26th. Shareholders of record on Thursday, May 31st will be paid a dividend of GBX 2.50 ($0.03) per share. This represents a yield of 1.12%. The ex-dividend date is Thursday, May 31st. This is a positive change from Spire Healthcare Group’s previous dividend of $1.30.

In other news, insider Justin Ash bought 46,500 shares of Spire Healthcare Group stock in a transaction on Tuesday, March 6th. The shares were bought at an average price of GBX 215 ($2.97) per share, with a total value of £99,975 ($138,125.17).

Spire Healthcare Group plc is a United Kingdom-based independent hospital group. The Company provides in-patient, daycase and out-patient care from approximately 40 hospitals, 10 clinics and over two specialist care centers across the United Kingdom. The Company also owns and operates a sports medicine, physiotherapy and rehabilitation brand, Perform, and a screening service, Lifescan, as well as national pathology services.

Receive News & Ratings for Spire Healthcare Group PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Spire Healthcare Group PLC and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply